arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2405.01616q-bio.BMcs.AIcs.LG
收藏

面向小分子蛋白质结合物搜索的生成式主动学习

Generative Active Learning for the Search of Small-molecule Protein Binders

Mila – Québec AI Institute(米拉-魁北克人工智能研究所);Dreamfold;McGill University(麦吉尔大学);Université de Montréal(蒙特利尔大学);IRIC, Université de Montréal(蒙特利尔大学IRIC研究所);Valence Labs(Valence实验室);X-Chem(X-Chem公司);MIT(麻省理工学院);AI Redefined
Maksym Korablyov, Cheng-Hao Liu, Moksh Jain, Almer M. van der Sloot, Eric Jolicoeur, Edward Ruediger, Andrei Cristian Nica, Emmanuel Bengio, Kostiantyn Lapchevs… 展开作者

Maksym Korablyov, Cheng-Hao Liu, Moksh Jain, Almer M. van der Sloot, Eric Jolicoeur, Edward Ruediger, Andrei Cristian Nica, Emmanuel Bengio, Kostiantyn Lapchevskyi, Daniel St-Cyr, Doris Alexandra Schuetz, Victor Ion Butoi, Jarrid Rector-Brooks, Simon Blackburn, Leo Feng, Hadi Nekoei, SaiKrishna Gottipati, Priyesh Vijayan, Prateek Gupta, Ladislav Rampášek, Sasikanth Avancha, Pierre-Luc Bacon, William L. Hamilton, Brooks Paige, Sanchit Misra, Stanislaw Kamil Jastrzebski, Bharat Kaul, Doina Precup, José Miguel Hernández-Lobato, Marwin Segler, Michael Bronstein, Anne Marinier, Mike Tyers, Yoshua Bengio

AI总结:

本文提出生成式主动学习方法LambdaZero,结合深度强化学习与分子对接,在可合成性和类药物性约束下高效设计sEH抑制剂,实现指数级加速并发现新型喹唑啉骨架先导化合物。

摘要:

尽管近年来机器学习在科学发现方面取得了实质性进展,但真正从头设计具有目标性质的小分子仍然是一个重大挑战。我们提出了LambdaZero,这是一种生成式主动学习方法,用于搜索可合成分子。在深度强化学习的驱动下,LambdaZero学习在广阔的分子空间中搜索,以发现具有所需性质的候选分子。我们将LambdaZero与分子对接相结合,设计能够抑制可溶性环氧化物水解酶2(sEH)的新型小分子,同时施加可合成性和类药物性约束。LambdaZero在调用昂贵的分子对接预言机的次数方面提供了指数级加速,并且LambdaZero从头设计的分子达到了原本需要对一千亿个分子进行虚拟筛选才能获得的对接分数。重要的是,LambdaZero发现了针对sEH的可合成、类药物抑制剂的新骨架。在体外实验验证中,一系列来自所生成的喹唑啉骨架的配体被合成出来,其中先导抑制剂N-(4,6-二(吡咯烷-1-基)喹唑啉-2-基)-N-甲基苯甲酰胺(UM0152893)对sEH表现出亚微摩尔级的酶抑制作用。

英文摘要:

Despite substantial progress in machine learning for scientific discovery in recent years, truly de novo design of small molecules which exhibit a property of interest remains a significant challenge. We introduce LambdaZero, a generative active learning approach to search for synthesizable molecules. Powered by deep reinforcement learning, LambdaZero learns to search over the vast space of molecules to discover candidates with a desired property. We apply LambdaZero with molecular docking to design novel small molecules that inhibit the enzyme soluble Epoxide Hydrolase 2 (sEH), while enforcing constraints on synthesizability and drug-likeliness. LambdaZero provides an exponential speedup in terms of the number of calls to the expensive molecular docking oracle, and LambdaZero de novo designed molecules reach docking scores that would otherwise require the virtual screening of a hundred billion molecules. Importantly, LambdaZero discovers novel scaffolds of synthesizable, drug-like inhibitors for sEH. In in vitro experimental validation, a series of ligands from a generated quinazoline-based scaffold were synthesized, and the lead inhibitor N-(4,6-di(pyrrolidin-1-yl)quinazolin-2-yl)-N-methylbenzamide (UM0152893) displayed sub-micromolar enzyme inhibition of sEH.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑